NIVESTYM
NIVESTYM
Approved
DIN Number
02485656
Drug Class
Human
Market Date
Jun 10, 2020
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02485656
AIG Number0123525001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L03AA02 FILGRASTIM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Subcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FILGRASTIMActive
Strength: 480 MCG / 1.6 ML
Monograph: FILGRASTIM